Investigator Sponsored Research
We are ready to find new ways to save lives.
At Day One, we are working hard to bring novel targeted therapies to children with brain cancer, and potentially others who can benefit.
We support Investigator-Sponsored Trials (ISTs) that advance medical and scientific knowledge in pediatric oncology and areas that support patient care.
We are ready to collaborate with researchers who share our passion. For IST support requests regarding tovorafenib and pimasertib please contact us at [email protected].
Day One provides no guarantees that it will support or fund any IST proposals. The terms of support, if any, will be set out in a written agreement between Day One and the investigator.